Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5UNITED THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank